Niagen Bioscience (NAGE) Cash & Equivalents Growth (5y) (2019 - 2026)
Niagen Bioscience (NAGE) Cash & Equivalents Growth (5y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Niagen Bioscience |
277.31 Mn |
210.76 Mn |
19.98 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
8.28% |
| Dec 31, 2025 |
31.15% |
| Jun 30, 2025 |
26.20% |
| Mar 31, 2025 |
32.52% |
| Dec 31, 2024 |
18.88% |
| Sep 30, 2024 |
11.41% |
| Jun 30, 2024 |
7.13% |
| Mar 31, 2024 |
7.36% |
| Dec 31, 2023 |
3.86% |
| Sep 30, 2023 |
-1.04% |
| Jun 30, 2023 |
-4.58% |
| Mar 31, 2023 |
-10.83% |
| Dec 31, 2022 |
-14.75% |
| Sep 30, 2022 |
-11.19% |
| Jun 30, 2022 |
3.84% |
| Mar 31, 2022 |
77.69% |
| Dec 31, 2021 |
76.62% |
| Sep 30, 2021 |
70.99% |
| Jun 30, 2021 |
63.00% |
| Mar 31, 2021 |
71.70% |
